Egros Fabrice

Director at SNDX

Sold, on record
$1M
Dollars the filings state
Form 4 sales
4
Latest Nov 18, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • SNDXSyndax Pharmaceuticals IncDirector

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale SNDXUnusual
    Mar 1, 2021 2021

    Sold 10,241 shares at $24.31 ($249k)

    Egros Fabrice, Director

    Sold 39% of holdings ($638k position)16,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale SNDXUnusual
    May 18, 2021 +78 days

    Sold 13,609 shares at $18.65 ($254k)

    Egros Fabrice, Director

    Sold 46% of holdings ($552k position)16,000 shares leftFiling

  3. 3 Form 4 sale SNDXUnusual
    Aug 18, 2021 +92 days

    Sold 15,635 shares at $15.75 ($246k)

    Egros Fabrice, Director

    Sold 49.4% of holdings ($498k position)16,000 shares leftFiling

  4. 4 Form 4 sale SNDXUnusual
    Nov 18, 2021 +92 days

    Sold 14,030 shares at $18.03 ($253k)

    Egros Fabrice, Director

    Sold 46.7% of holdings ($541k position)16,000 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Egros Fabrice
Source
Nov 18, 2021Nov 19, 2021SNDXDirectorForm 4 sale14,030$253k46.7%UnusualSEC
Aug 18, 2021Aug 20, 2021SNDXDirectorForm 4 sale15,635$246k49.4%UnusualSEC
May 18, 2021May 20, 2021SNDXDirectorForm 4 sale13,609$254k46.0%UnusualSEC
Mar 1, 2021Mar 3, 2021SNDXDirectorForm 4 sale10,241$249k39.0%UnusualSEC